KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gilead Sciences (GILD) Receivables - Net (2016 - 2025)

Historic Receivables - Net for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $5.1 billion.

  • Gilead Sciences' Receivables - Net rose 1107.48% to $5.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 billion, marking a year-over-year increase of 1107.48%. This contributed to the annual value of $5.3 billion for FY2024, which is 1414.16% up from last year.
  • Per Gilead Sciences' latest filing, its Receivables - Net stood at $5.1 billion for Q3 2025, which was up 1107.48% from $5.6 billion recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Receivables - Net ranged from a high of $5.6 billion in Q2 2025 and a low of $3.8 billion during Q1 2022
  • For the 5-year period, Gilead Sciences' Receivables - Net averaged around $4.7 billion, with its median value being $4.8 billion (2022).
  • Examining YoY changes over the last 5 years, Gilead Sciences' Receivables - Net showed a top increase of 5366.31% in 2021 and a maximum decrease of 1919.06% in 2021.
  • Quarter analysis of 5 years shows Gilead Sciences' Receivables - Net stood at $4.5 billion in 2021, then increased by 6.32% to $4.8 billion in 2022, then fell by 2.45% to $4.7 billion in 2023, then increased by 14.14% to $5.3 billion in 2024, then dropped by 4.21% to $5.1 billion in 2025.
  • Its last three reported values are $5.1 billion in Q3 2025, $5.6 billion for Q2 2025, and $5.3 billion during Q1 2025.